Anastrozole
Letrozole
Fulvestrant
Darunavir
Rocuronium bromide
Entecavir
Iron Sucrose
Strontium Ranelate
Ibandronate Sodium
Palonosetron HCl
Bosentan hydrate
Lercanidipine HCl
Add.: 8# xiyuan no.1 road , westlake technologe park, sandun, hangzhou.
Tel: +86-571-88298691 89905385
Fax: +86-571-87353175
E-mail: sales@hetapharm.com
Web: www.hetapharm.com

 

HETA Pharm has been engaged in innovative research and development for almost a decade now. During this period, it has made significant progress, mainly in two therapeutic fields: oncology diseases and oncology assistant treatments. Other therapeutic areas are emerging as potential areas of research. The R & D department has eminent research scientists with excellent professional records in the field of domestic chemicals and pharmaceuticals, they focused on activities encompassing Pharmacology, Toxicology, Registration, and Product development. Collaborative assignments, both within the company and with research institutes .Most of the pipe-line projects are based on research performed in the leading research institutes.


This pioneering spirit drives the research efforts for drug discovery and development at Discovery Research, a Strategic Business Unit of HETA Pharm. All Research and Development (R & D) at Discovery Research is focused on the goal of developing breakthrough treatments that will make a real difference in patients' lives.

 

Copyright(C)2005,Hangzhou HETA Pharm & Chem Co.,Ltd., All Rights Reserved.Supported by ChemNet ChinaChemNet Toocle